Ancillary measures in treatment of myeloma. Use of immune serum globulin, fluoride, or androgen.
We reviewed the efficacy of three agents advocated as ancillary therapy in myeloma patients. Intramuscularly administered immune serum globulin (gamma globulin) was ineffective in preventing infection. Hemoglobin level was improved in some myeloma patients receiving androgens. However, the response rate and the degree of leukopenia or thrombocytopenia were not superior with androgen-melphalan-prenisone combination therapy, as compared with those resulting from the two-drug combination without androgen. A controlled study evaluating androgen plus melphalan has not been done. The long-term administration of fluoride, supplemented by calcium and androgen, induced radiologically apparent bone fluorosis, but strengthening of lytic bone was not observed. Neither objective nor subjective benefit was demonstrated in a controlled study comparing the effects of fluoride (without calcium supplement) with those of the placebo.
D000728:Androgens / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000628:therapy*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005459:Fluorides / Q000008:administration & dosage / Q000627:therapeutic use*; D005474:Fluoxymesterone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D013739:Testosterone / Q000008:administration & dosage / Q000627:therapeutic use; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
D000728:Androgens; D005719:gamma-Globulins; D013739:Testosterone; D005474:Fluoxymesterone; D008558:Melphalan; D005459:Fluorides; D011241:Prednisone